A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies

计划入组 1 人 · 首次发布于 2013 年 5 月 21 日

Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76

计划入组 1,016 人 · 首次发布于 2013 年 8 月 2 日

Utility of a Measure of Lupus Low Disease Activity State (LLDAS) in SLE

计划入组 1,684 人 · 首次发布于 2016 年 5 月 11 日

Spinal Bliss

NIM-76

CU-76

BLISS GVS PHARMA LIMITED

India

Bliss Biopharmaceutical (Hangzhou) Co., Ltd.

China

贵阳制药厂

Belimumab Shows Superior Outcomes in Pediatric Lupus Nephritis Treatment Study

Belimumab Shows Superior Efficacy for Systemic Lupus Erythematosus in Meta-Analysis

High Placebo Response Rates Challenge Lupus Drug Development as Researchers Develop New Trial Strategies